Search
Descriptor English: Febuxostat
Descriptor Spanish: Febuxostat
Descriptor Portuguese: Febuxostat
Descriptor French: Fébuxostat
Entry term(s): 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylic acid
6720, TEI
TEI 6720
TEI-6720
TEI6720
Uloric
Tree number(s): D02.886.675.274
D03.383.129.708.274
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D000069465
Scope note: A thiazole derivative and inhibitor of XANTHINE OXIDASE that is used for the treatment of HYPERURICEMIA in patients with chronic GOUT.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Gout Suppressants
Registry Number: 101V0R1N2E
CAS Type 1 Name: 5-Thiazolecarboxylic acid, 2-(3-cyano-4-(2-methylpropoxy)phenyl)-4-methyl-
Public MeSH Note: 2016; FEBUXOSTAT was indexed under THIAZOLES 1994-2015
History Note: 2016 (1994)
DeCS ID: 55905
Unique ID: D000069465
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2016/01/01
Date of Entry: 2015/07/01
Revision Date: 2016/05/31
Febuxostat - Preferred
Concept UI M0224789
Scope note A thiazole derivative and inhibitor of XANTHINE OXIDASE that is used for the treatment of HYPERURICEMIA in patients with chronic GOUT.
Preferred term Febuxostat
TEI 6720 - Narrower
Concept UI M0473600
Preferred term TEI 6720
Entry term(s) 6720, TEI
TEI-6720
TEI6720
Uloric - Narrower
Concept UI M0544237
Preferred term Uloric
2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylic acid - Narrower
Concept UI M0224787
Preferred term 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylic acid



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.


Go to survey